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The Relationship Between Volume and Outcome Following Elective
Open Repair of Abdominal Aortic Aneurysms (AAA) in 131 German
Hospitals
Eckstein H.-H., Bruckner T., Heider P., Wolf O., Hanke M., Niedermeier
H.-P., Noppeney T., Umscheid T., Wenk H. Eur J Vasc Endovasc Surg
2007;34:260-6.
Objectives: Several studies indicate that high-volume hospitals have
better results in open repair of unruptured abdominal aortic aneurysms
(AAA). Up to now no studies had addressed this question in German
hospitals.
Design: Post-hoc-analysis from a prospective physician-led registry.
Material and methods: Since 1999, the German Society for Vascular
Surgery has conducted a prospective registry for open and endovascular
repair of AAAs. This study includes 131 hospitals who conducted n10163
elective open repairs for unruptured AAA between 1999 to 2004. All
perioperative variables including annual volume as a continuous variable
were analysed in a step-wise logistic regression model. In order to define a
threshold annual volume an additional logistic regression analysis was per-
formed by use of annual volume groups (0–9, 10–19, 20–29, 30–39,
40–49, 50 or more). The relationship between annual volume and further
outcome parameters (length of procedure, blood transfusion, length of stay)
were also analyzed.
Results: The overall mortality rate was 3.2%. The stepwise logistic
regression model identified the following predictors of an increased periop-
erative mortality: age (OR 1.084, 95% CI 1.066–1.102), AAA diameter
(OR 1.008, 95% CI 1.001–1.016), length of procedure (OR 1.008, 95% CI
1.006–1.009), ASA-Score (OR 2.636, 95% CI 2.129–3.264), suprarenal
clamping (OR 1.447, 95% CI 1.008–2,078), blood transfusion (OR 1.786,
95% CI 1.268–2.514). Annual volume was moderately predictive (OR
1.003, 95% CI 1–1.006) but failed to reach statistical significance (p0.07).
The analysis of volume groups identified a significantly higher risk for
hospitals with an annual volume of 1-9 AAA-repairs by comparison to
hospitals with an annual volume of 50 or more AAA-repairs (OR 1.903, 95%
CI 1.124–3.222). Operations at low volume hospitals were also longer
(p0.001), with an extended postoperative stay (p0.001) and a higher
transfusion rate (p0.001).
Conclusions: Patient’s age, ASA classification, AAA diameter, length
of procedure, suprarenal clamping and blood transfusion are predictive
variables for an increased perioperative mortality in elective open AAA
repair.Mortality is also increased by a low annual volume. Further studies are
needed to examine whether these data are applicable to all German hospitals.
Fast Track Open Aortic Surgery: Reduced Post Operative Stay with a
Goal Directed Pathway
Murphy M.A., Richards T., Atkinson C., Perkins J., Hands L.J. Eur J Vasc
Endovasc Surg 2007;34:274-8.
Objective: Open aortic aneurysm repair is traditionally associated
with an extended hospital stay. The aim of this study was to examine the
feasibility of reducing post-operative stay through the implementation of
a fast –track, goal directed, clinical pathway for elective open aortic
surgery.
Methods: A fast-track clinical pathway for aortic surgery was intro-
duced in a regional vascular unit in September 2005. The pathway has daily
goals and targets discharge for all patients on the 3rd post operative day. This
study compares thirty consecutive discharges of unselected patients under-
going elective infra-renal aortic surgery following introduction of the path-
way to the thirty consecutive cases preceding its introduction. Reasons for
prolonged hospital stay were recorded.
Results: Six of thirty patients achieved discharge by Day 3. The median
hospital stay reduced from 9 (range 4 to 17days) to 5 days (range 2 to 12
days) following introduction of the pathway. There was one readmission
within 30 days and no complications attributable to the pathway implemen-
tation. Cardiac complications and home planning were the most common
causes of delayed discharge.
Conclusion: Post-operative stay in patients undergoing standard elec-
tive open infra-renal aortic surgery can be safely reduced with the introduc-
tion of a goal directed pathway.
Secondary Interventions andMortality Following Endovascular Aortic
Aneurysm Repair: Device-specific Results from the UK EVAR Trials
The EVAR Trial Participants. Eur J Vasc Endovasc Surg 2007;34:281-90.
Objectives:To compare secondary intervention rate, aneurysm-related
mortality and all-cause mortality for patients receiving elective endovascular
aneurysm repair (EVAR) for large abdominal aortic aneurysms with different
commercially available endografts.
Design, materials & methods: In the EVAR 1 and 2 multi-centre
trials, the principal endografts used were Zenith and Talent and these are
compared in 505 patients from EVAR 1 and 143 patients from EVAR 2
followed-up for an average of 3.8 years until 31st December 2005. Out-
comes were analysed by Cox proportional hazards regression, with adjust-
ments for potential confounding risk factors and centre. Gore/Excluder
graft outcomes also are reported.
Results: Across the two trials the secondary intervention rates were 7.0
and 9.4 per 100 patient years for Zenith and Talent grafts respectively,
adjusted hazard ratio 0.77 [95%CI 0.52–1.12]. Aneurysm-related mortality
was 1.2 and 1.4 per 100 patient years for Zenith and Talent grafts respec-
tively, adjusted hazard ratio 0.90 [95%CI 0.37–2.19]. All-cause mortality
was 8.5 and 10.3 per 100 patient years for Zenith and Talent grafts
respectively, adjusted hazard ratio 0.81 [95%CI 0.58–1.14]. The direction
of all results was similar when the two trials were analysed separately.
Conclusion: There was no significant difference in the performance of
the two endografts but the direction of results was slightly in favour of
patients with Zenith (versus Talent) endografts.
AModular Aortouniiliac Graft is a Useful Device for the Treatment of
Symptomatic and Ruptured Infrarenal, Abdominal Aortic Aneurysms:
One-year Results
Hinchliffe R.J., Braithwaite B.D., European BiFab Study Collaborators. Eur
J Vasc Endovasc Surg 2007;34:291-8.
Introduction: Endovascular repair (EVAR) of acute symptomatic and
ruptured abdominal aortic aneurysm (rAAA) can be difficult without a large
stock of suitable graft sizes. We report a prospective European multicentre
study of a modular aortouniiliac stent-graft.
Patients and methods: Seven centres, with elective EVAR experience,
participated in the study. Sixty-five patients were enrolled from September
2002 – April 2005. Some 45 patients had rAAA and 20 were acutely
symptomatic. Their median age was 74 (69–80.3) years, 49 (75%) were
men. From a choice of 4 body and 4 limb sizes, stent-grafts were deployed
under local or general anaesthesia.
Results: The endovascular delivery system was introduced and the
aneurysm excluded from the circulation in a median of 40 (30–60) minutes
from the first incision.
The median operative duration was 150 (120–190) mins, blood loss
300 ml (200–800). 33 (51%) operations were performed by a vascular
surgeon alone.
There were a total of 4 (6%) peri-operative re-interventions, endovas-
cular (n1), open (n2) and thrombectomy (n1). The peri-operative
mortality in the rupture group was 40% and 10% in the symptomatic group.
Conclusions: Aortouniiliac stent-grafts provide rapid exclusion of
rAAA. Suitably trained surgeons can do the operation without a radiologist’s
support. The mortality rate from rAAA treated with EVAR remains high.
Carotid Sinus Nerve Blockade to Reduce Blood Pressure Instability
Following Carotid Endarterectomy: A Systematic Review and
Meta-analysis
Tang T.Y., Walsh S.R., Gillard J.H., Varty K., Boyle J.R., Gaunt M.E. Eur J
Vasc Endovasc Surg 2007;34:304-11.
Objectives: Local anaesthetic infiltration into the carotid sinus during
carotid endarterectomy (CEA) has been recommended to minimise blood
pressure fluctuations but its use remains controversial. The aim of this
meta-analysis was to determine whether intra-operative administration of
local anaesthetic reduces the incidence of haemodynamic instability follow-
ing CEA.
Materials and methods: A search of the Medline, Pubmed and
Embase databases and the Current Controlled Trials register identified four
trials, which met the pre-defined inclusion criteria for data extraction.
Pooled odds ratios with 95 per cent confidence intervals (c.i.) for the
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development of post-operative hypotension and hypertension were calcu-
lated using a random-effects model.
Results: Outcomes of 432 patients were studied. Local anaesthetic
blockade of the carotid sinus was associated with a pooled odds ratio of 1.25
(95 per cent c.i. 0.496 to 3.15); p0.216) and 1.28 (95 per cent c.i. 0.699
to 2.33; p0.428) for the development of post-operative hypotension and
hypertension respectively. Although none reach significance there was a
trend towards increased risk of developing a complication in those patients
who received local anaesthetic.
Conclusions: There are insufficient data to determine the role of
intra-operative local anaesthetic administration in reducing post-operative
blood pressure lability following CEA. Conversely, the possibility of harm
cannot be excluded on the basis of the currently available data.
Medical Therapy for Intermittent Claudication
Rowlands T.E., Donnelly R. Eur J Vasc Endovasc Surg 2007;34:314-21.
Medical therapy to improve symptoms, stabilise the underlying vascular
disease and improve lower limb outcomes is an important and effective
adjunct to lifestyle modification and surgical or endovascular interventions
in patients with IC. Randomised placebo controlled trials have shown that
the phosphodiesterase III inhibitor cilostazol 100 mg bid improves pain-
free and maximum walking distance, as well as quality of life, in a range of
patients with intermittent claudication in whom there is no evidence of tissue
necrosis or rest pain. This review summarises the evidence from 8 pivotal
trials of cilostazol involving over 2000 patients with intermittent claudica-
tion treated for up to 6 months. There is comparatively less evidence to
support the use of other treatment modalities for relief of symptoms in
intermittent claudication, but there is considerable interest in therapeutic
angiogenesis to promote new vessel formation and enhance collateralisation
of the lower limb using recombinant growth factor proteins or gene transfer
strategies. The rationale for therapeutic angiogenesis is discussed, together
with the most recent results from randomised trials in patients with periph-
eral arterial disease.
Supervised Exercise Training for Intermittent Claudication: Lasting
Benefit at Three Years
Ratliff D.A., Puttick M., Libertiny G., Hicks R.C.J., Earby L.E, Richards T.
Eur J Vasc Endovasc Surg 2007;34:322-6.
Objectives: To assess the long-term outcome of supervised exercise
training for intermittent claudication.
Methods:A prospective study was undertaken of all patients referred to
a single centre with intermittent claudication (46 m). Patients underwent
supervised exercise training twice weekly for 10 weeks, with regular
follow-up to 3 years. Actual ClaudicationDistance (ACD),MaximumWalking
Distance (MWD) and ankle-brachial pressure indices (ABPI) were measured.
Results: In 202 patients the initial median ACD and MWD were
112 m and 197 m. Following exercise therapy both the median ACD and
MWD increased to 266 m and 477 m at three months, increases of
237% and 242% respectively (p0.001). At three years the median ACD
and MWD were 250 m and 372 m, increases of 223% and 188% respec-
tively (p0.001). There was no significant change in ACD or MWD at
3 months compared to 1, 2 or 3 years. ABPI remained unchanged
throughout.
Conclusions: Supervised exercise training has long term benefit in
patients with intermittent claudication. Results seen at 12 weeks are sus-
tained at three years.
Randomised Trial of Polytetrafluoroethylene Patch Insertion for Re-
current Great Saphenous Varicose Veins
Winterborn R.J., Earnshaw J.J. Eur J Vasc Endovasc Surg 2007;34:367-73.
Objectives: The aim of this study was to assess the possible value of a
polytetrafluoroethylene (PTFE) patch in the treatment of recurrent varicose
veins.
Methods:Thirty-one patients (40 legs) with recurrent saphenofemoral
junction incompetence were randomised to redo saphenofemoral ligation
and great saphenous vein stripping with, or without the insertion of a PTFE
patch over the ligated junction. Patients underwent assessment preopera-
tively, and at 6 weeks, 1 year and 2 years postoperatively with clinical
examination, duplex imaging and completion of the Aberdeen Varicose Vein
Symptom Severity Score (AVVSSS).
Results: A total of 27 patients (32 legs) attended for assessment at 6
weeks, 25 patients (30 legs) at 1 year and 27 patients (32 legs) at 2 years.
At 6 weeks, seven legs (22%) had an area of cutaneous numbness; all but
one had resolved by 1 year. Four legs (13%) developed a groin infection,
which required antibiotics, 2 had a groin haematoma and four had a
seroma, all of which resolved spontaneously. The overall complication
rate was 35% (11 legs), with no statistically significant difference between
the groups. Four of 16 legs without a patch and five of 16 legs with a
patch developed neovascularisation at the saphenofemoral junction on
duplex imaging by two years postoperatively. Two cases of neovasculari-
sation in the patch group and one in the no patch group directly resulted
in clinical recurrence (p1.0). There was an improvement in patients’
AVVSSS two years postoperatively (p0.03), that was similar in both
groups.
Conclusions: In this study, insertion of a PTFE patch did not affect the
rate of perioperative complications and it did not appear to contain neovas-
cularisation.
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